Preclinical models that recapitulate aspects of human airway disease are essential for the advancement of novel therapeutics and vaccines. In the current study published in the journal mBIO, researchers at Baylor College ...
Feb 15, 2022
0
131
As any parent knows, infants are prone to getting respiratory infections. But a new study shows that the infant immune system is stronger than most people think and beats the adult immune system at fighting off new pathogens.
Dec 10, 2021
0
284
The COVID-19 pandemic and resurgence of infections by other respiratory RNA viruses such as respiratory syncytial virus (RSV) in children has caused an urgent need for the development of orally available broad-spectrum antiviral ...
Dec 2, 2021
0
166
Infection with respiratory syncytial virus during infancy results in metabolic reprogramming of epithelial cells lining the airway, according to a Northwestern Medicine study published in the journal Viruses.
Nov 22, 2021
0
73
Using the same approach they recently used to create effective vaccine candidates against COVID-19 and respiratory syncytial virus (RSV), scientists are tackling another virus: the tick-borne Crimean-Congo hemorrhagic fever ...
Nov 18, 2021
0
75
When scientists were developing a vaccine against COVID-19, a key worry was the potential to cause disease enhancement. It's a complication that occurs when a vaccine does the opposite of what it's intended to do and instead ...
Oct 25, 2021
0
436
Bronchiolitis—the most common lung infection in young children, and which is most often caused by respiratory syncytial virus, or RSV—is the leading cause of hospitalizations in U.S. infants, and about 30% of those with ...
Jun 14, 2021
0
12
Children hospitalized with breathing problems due to a common viral lung infection are likely to get sicker and remain hospitalized if they have high levels of defective copies of the virus, according to a new study by researchers ...
Apr 1, 2021
0
23
Researchers from the University of Nottingham have discovered a novel antiviral property of a drug that could have major implications in how future epidemics / pandemics—including COVID-19—are managed.
Feb 2, 2021
1
1577
Measures to reduce the spread of COVID-19 through non-pharmaceutical interventions (NPIs) such as mask wearing and social distancing are a key tool in combatting the impact of the ongoing coronavirus pandemic. These actions ...
Nov 10, 2020
3
58
